The new national cholesterol education program guidelines

被引：34

作者：

Eidelman, RS ^{[1
]}

Lamas, GA ^{[1
]}

Hennekens, CH ^{[1
]}

机构：

[1] Mt Sinai Med Ctr, Miami Beach, FL 33140 USA

来源：

ARCHIVES OF INTERNAL MEDICINE | 2002年 / 162卷 / 18期

关键词：

D O I：

10.1001/archinte.162.18.2033

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2033 / 2036

页数：4

共 23 条

[1]

AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917

[2] Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors -: The role of metabolism -: Monograph for physicians [J].

Bottorff, M .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (15) :2273-2280

[3] DECREASED HDL2 AND HDL3 CHOLESTEROL, APO A-I AND APO A-II, AND INCREASED RISK OF MYOCARDIAL-INFARCTION [J].

BURING, JE ;

OCONNOR, GT ;

GOLDHABER, SZ ;

ROSNER, B ;

HERBERT, PN ;

BLUM, CB ;

BRESLOW, JL ;

HENNEKENS, CH .

CIRCULATION, 1992, 85 (01) :22-29

[4] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[5] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].

Downs, JR ;

Clearfield, M ;

Weis, S ;

Whitney, E ;

Shapiro, DR ;

Beere, PA ;

Langendorfer, A ;

Stein, EA ;

Kruyer, W ;

Gotto, AM .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622

[6]

Ducobu J, 2000, Rev Med Brux, V21, P11

[7] Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047 [J].

Fichtenbaum, CJ ;

Gerber, JG ;

Rosenkranz, SL ;

Segal, Y ;

Aberg, JA ;

Blaschke, T ;

Alston, B ;

Fang, F ;

Kosel, B ;

Aweeka, F .

AIDS, 2002, 16 (04) :569-577

[8]

GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015

[9] Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials [J].

Hebert, PR ;

Gaziano, JM ;

Chan, KS ;

Hennekens, CH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04) :313-321

[10] Increasing burden of cardiovascular disease - Current knowledge and future directions for research on risk factors [J].

Hennekens, CH .

CIRCULATION, 1998, 97 (11) :1095-1102

← 1 2 3 →